NFKB1 and cancer: COVID-19 is concomitant with activation of oncogenic pathways, including The Janus kinase signal transducer and activator of transcription)JAK-STAT (, mitogen-activated protein kinase (MAPK), and Nuclear factor kappa B (NF-κB), which potentially can increase the risk of cancer (Li et al., 2020a).